Table 2.

Maximum daratumumab Ctrough for DARA-MD 1200 mg, DARA-MD 1800 mg, and historical data for daratumumab 16 mg/kg IV

VariableDose and route of administrationNo. of patientsMean daratumumab Ctrough on cycle 3 day 1, µg/mLCV, %
DARA-MD (PAVO) 1200 mg SC 543.90 44 
DARA-MD (PAVO) 1800 mg SC 42 744.20 52 
Daratumumab (GEN501) 16 mg/kg IV 27 617.17 51 
Daratumumab (SIRIUS)16  16 mg/kg IV 73 573.49 58 
VariableDose and route of administrationNo. of patientsMean daratumumab Ctrough on cycle 3 day 1, µg/mLCV, %
DARA-MD (PAVO) 1200 mg SC 543.90 44 
DARA-MD (PAVO) 1800 mg SC 42 744.20 52 
Daratumumab (GEN501) 16 mg/kg IV 27 617.17 51 
Daratumumab (SIRIUS)16  16 mg/kg IV 73 573.49 58 

CV, coefficient of variation; SC, subcutaneously.

Close Modal

or Create an Account

Close Modal
Close Modal